Skip to main content

Sutro Biopharma, Inc.

STRO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001382101

No open-market purchases or sales by Sutro Biopharma, Inc. insiders were filed in the last 90 days; 100 institutions reported holding it in 13F filings for Q2 2026, worth $545.7M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Sutro Biopharma, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of STRO: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders115113−2
Shares46.1M50.4M+4.30M (+9.3%)
Value$240.9M$279.6M+$38.7M (+16.0%)

New holders (10)

Institutions that held Sutro Biopharma, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to STRO in Q3 2022
InstitutionSharesValue% of portfolio
Point72 Asset Management, L.P.711,000$3.95M0.02%
Ameriprise Financial Inc82,551$457.0K0.00%
Trexquant Investment LP57,869$321.0K0.01%
Jump Financial, LLC45,900$255.0K0.01%
Engineers Gate Manager LP19,790$110.0K0.01%
Principal Financial Group Inc10,392$58.0K0.00%
Prudential Financial Inc10,070$56.0K0.00%
Allspring Global Investments Holdings, LLC9,281$51.0K0.00%
Quantbot Technologies LP6,712$37.0K0.00%
China Universal Asset Management Co., Ltd.488$3.00K0.00%

Sold out (12)

Institutions that held Sutro Biopharma, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of STRO in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Banco Santander, S.A.400,000$2.08M
Graham Capital Management, L.P.251,921$1.31M
HRT Financial LP162,006$844.0K
Kennedy Capital Management, Inc.114,437$596.0K
Ergoteles LLC84,309$439.0K
Squarepoint Ops LLC34,041$177.0K
Qube Research & Technologies Ltd29,298$153.0K
Point72 Hong Kong Ltd8,833$46.0K
Skandinaviska Enskilda Banken AB (publ)5,100$27.0K
Fairfield, Bush & Co.2,000$10.0K
Captrust Financial Advisors120$1.00K
Total Clarity Wealth Management, Inc.200$1.00K